Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

276 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Locoregional control and toxicity after pleurectomy/decortication and intensity-modulated pleural radiation therapy in patients with malignant pleural mesothelioma.
Arrieta O, Lozano-Ruiz F, Blake-Cerda M, Catalán R, Lara-Mejía L, Salinas MÁ, Maldonado-Magos F, Corona-Cruz JF. Arrieta O, et al. Among authors: catalan r. Thorac Cancer. 2020 Dec;11(12):3448-3455. doi: 10.1111/1759-7714.13668. Epub 2020 Oct 8. Thorac Cancer. 2020. PMID: 33030313 Free PMC article.
Cost-effectiveness analysis of first and second-generation EGFR tyrosine kinase inhibitors as first line of treatment for patients with NSCLC harboring EGFR mutations.
Arrieta O, Catalán R, Guzmán-Vazquez S, Barrón F, Lara-Mejía L, Soto-Molina H, Ramos-Ramírez M, Flores-Estrada D, de la Garza J. Arrieta O, et al. Among authors: catalan r. BMC Cancer. 2020 Sep 1;20(1):829. doi: 10.1186/s12885-020-07329-8. BMC Cancer. 2020. PMID: 32873256 Free PMC article.
Risk of Developing Checkpoint Immune Pneumonitis and Its Effect on Overall Survival in Non-small Cell Lung Cancer Patients Previously Treated With Radiotherapy.
Barrón F, Sánchez R, Arroyo-Hernández M, Blanco C, Zatarain-Barrón ZL, Catalán R, Ramos-Ramírez M, Cardona AF, Flores-Estrada D, Arrieta O. Barrón F, et al. Among authors: catalan r. Front Oncol. 2020 Sep 29;10:570233. doi: 10.3389/fonc.2020.570233. eCollection 2020. Front Oncol. 2020. PMID: 33117699 Free PMC article.
Efficacy, Safety, and Cost-Minimization Analysis of Continuous Infusion of Low-Dose Gemcitabine Plus Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma.
Arrieta O, Muñoz-Montaño W, Muñiz-Hernández S, Campos S, Catalán R, Soto-Molina H, Guzmán Vázquez S, Díaz-Álvarez O, Martínez-Pacheco V, Turcott JG, Ramos-Ramírez M, Cabrera-Miranda L, Barrón F, Cardona AF. Arrieta O, et al. Among authors: catalan r. Front Oncol. 2021 Apr 20;11:641975. doi: 10.3389/fonc.2021.641975. eCollection 2021. Front Oncol. 2021. PMID: 33959504 Free PMC article.
Association of Lung Adenocarcinoma Subtypes According to the IASLC/ATS/ERS Classification and Programmed Cell Death Ligand 1 (PD-L1) Expression in Tumor Cells.
Cruz-Rico G, Avilés-Salas A, Popa-Navarro X, Lara-Mejía L, Catalán R, Sánchez-Reyes R, López-Sánchez D, Cabrera-Miranda L, Aquiles Maldonado-Martínez H, Samtani-Bassarmal S, Arrieta O. Cruz-Rico G, et al. Among authors: catalan r. Pathol Oncol Res. 2021 Apr 8;27:597499. doi: 10.3389/pore.2021.597499. eCollection 2021. Pathol Oncol Res. 2021. PMID: 34257548 Free PMC article.
RRM1 and ERCC1 as biomarkers in patients with locally advanced and metastatic malignant pleural mesothelioma treated with continuous infusion of low-dose gemcitabine plus cisplatin.
Muñoz-Montaño W, Muñiz-Hernández S, Avilés-Salas A, Catalán R, Lara-Mejía L, Samtani-Bassarmal S, Cardona AF, Mendoza-Desión J, Hernández-Cueto D, Maldonado A, Baay-Guzmán G, Huerta-Yepes S, Arrieta O. Muñoz-Montaño W, et al. Among authors: catalan r. BMC Cancer. 2021 Aug 5;21(1):892. doi: 10.1186/s12885-021-08287-5. BMC Cancer. 2021. PMID: 34353292 Free PMC article.
Modifying factors of PD-L1 expression on tumor cells in advanced non-small-cell lung cancer.
Avilés-Salas A, Flores-Estrada D, Lara-Mejía L, Catalán R, Cruz-Rico G, Orozco-Morales M, Heredia D, Bolaño-Guerra L, Soberanis-Piña PD, Varela-Santoyo E, Cardona AF, Arrieta O. Avilés-Salas A, et al. Among authors: catalan r. Thorac Cancer. 2022 Dec;13(23):3362-3373. doi: 10.1111/1759-7714.14695. Epub 2022 Oct 31. Thorac Cancer. 2022. PMID: 36317227 Free PMC article.
LKB1 Loss Assessed by Immunohistochemistry as a Prognostic Marker to First-Line Therapy in Advanced Non-Small-Cell Lung Cancer.
Avilés-Salas A, Díaz-García DA, Lara-Mejía L, Cardona AF, Orozco-Morales M, Catalán R, Hernández-Pedro NY, Rios-Garcia E, Ramos-Ramírez M, Arrieta O. Avilés-Salas A, et al. Among authors: catalan r. Curr Oncol. 2022 Dec 26;30(1):333-343. doi: 10.3390/curroncol30010027. Curr Oncol. 2022. PMID: 36661676 Free PMC article.
276 results